Pfizer Inc.
$29.71
+0.26 · +0.88% today
Market open · updated 12:44:26 PM ET
- High
- $29.73 4:15 AM
- Low
- $29.71 4:05 AM
Against the S&P 500 Price change through Oct 28, 2026
PFE+18.27%
S&P 500+13.26%
PFE+20.20%
S&P 500+12.41%
PFE−2.19%
S&P 500+88.06%
PFE−31.80%
S&P 500+68.51%
Key numbers
- Previous close
- $29.45
- Open
- $29.99
- Day's range
- $29.66 – $30.18
- 52-week range
- $23.62 – $30.44
- Volume
- 9.7 million
- Average volume
- 37.4 million
- Market value
- $169.3 billion
- Price to earnings
- 38.9last 12 months
- Earnings per share
- $0.76last 12 months
- Beta
- 0.28moves less than the market
- Dividend
- $1.72 a year · 5.84%
- 50-day average
- $28.46
- 200-day average
- $26.75
Tuesday, Nov 3, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Pfizer buys from and competes with From our value chain
Pfizer in the news
No desk stories on PFE yet. When we write about it, the story leads this list.
- HeadlinePfizer (PFE) Stock Sinks As Market Gains: Here's WhyZacks Investment Research · October 28, 2026 at 6:46 PM ET
- HeadlinePfizer Stock Ahead of Q3 Earnings: To Buy or Not to Buy?Zacks Investment Research · October 28, 2026 at 12:31 PM ET
- HeadlinePfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research · October 27, 2026 at 11:01 AM ET
- HeadlinePfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple MyelomaBusiness Wire · October 27, 2026 at 6:45 AM ET
- HeadlinePfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment SettingBusiness Wire · October 26, 2026 at 1:41 PM ET
- HeadlinePfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026Business Wire · October 24, 2026 at 11:18 AM ET
- HeadlinePfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemThe Motley Fool · October 24, 2026 at 3:00 AM ET
- HeadlineBristol Myers Squibb vs. Pfizer: Consistency vs.The Motley Fool · October 22, 2026 at 5:25 PM ET
Earnings
Next report: Tuesday, Nov 3, 2026, before the open.
Congress trades in PFE
5 purchases and 3 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 25, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 11, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Sale | $15,001 - $50,000 | Sep 4, 2026 | Oct 9, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Jul 7, 2026 | Aug 12, 2026 |
| Michael RulliHouse · R-Ohio | Sale | $1,001 - $15,000 | Nov 26, 2024 | Aug 10, 2026 |
| Tommy TubervilleSenate · R-Alabama | Sale | $15,001 - $50,000 | Jun 8, 2026 | Jul 16, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Apr 13, 2026 | May 13, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Feb 10, 2026 | Mar 10, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Pfizer
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 75,000
- Headquarters
- New York City, New York
- Website
- pfizer.com
- Listed
- Jun 1, 1972
More drug manufacturers - general stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.